3.68 USD
▼-0.35-8.68%
盘后 3.97 0.00%
2026-09-16
市值
$6.99M
市盈率
—
EPS
-16.38
股息率
—
52 周区间
3.13 – 7.20
成交量
28.74K
Beta
1.09
目标价
29.00
52W 低 3.1352W 高 7.20
价格走势
公司简介
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company’s pipeline products include BDC-4182, a next-generation Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program for the treatment of non-small cell lung cancer, melanoma, and other solid tumors; CEA ISAC, a Boltbody ISAC targeting carcinoembr...